Micro Interventional Devices initiates 1st-in-man EU study for its Permaseal
Symetis
Heart valves: Edwards Lifesciences, Medtronic to face stiffer competition
It’s not your father’s transcatheter aortic valve implant anymore.
Next year and the year after, the competitive landscape for TAVI will explode, with as many as 12 competing devices on the market here and across the pond.
And that competition will be fierce. As TAVI celebrates its 10th birthday,at least 1 analyst is predicting a 20%+ compound annual growth rate for the market, which she says could potentially double by 2015.